Kao (4452) Status update summary
Event summary combining transcript, slides, and related documents.
Status update summary
26 Aug, 2026Strategic vision and business environment
Aims to become a global leader by leveraging scientific and emotional brand strengths, fusing scientific evidence with sensory appeal, and creating distinctive brands.
Seeks to establish a stable revenue base by 2027, focusing on global consistency and local flexibility amid a rapidly changing cosmetics market.
Implements a global management structure, emphasizing cross-border collaboration and organizational restructuring.
Growth strategy and brand focus
Focuses on six global/core brands: SENSAI, MOLTON BROWN, KANEBO, SOFINA, Curél, and KATE, each with tailored growth strategies and a scrum-style, borderless operation for global expansion.
Achieved 15% year-on-year growth for focus brands in Japan and 34% growth in e-commerce, with significant cost reductions.
Divides brands into Japan origin, Europe origin, and Asia models to maximize investment efficiency and success rates.
Market expansion and operational improvements
Curél targets European expansion, leveraging its derma care reputation and proprietary ceramide technology.
SENSAI and MOLTON BROWN expand from Europe into Asia, targeting 2.5x sales growth in Asia, while KANEBO and KATE aim for 2.5x growth in Thailand and focus on Asian growth.
SOFINA integrates all series into One SOFINA, launching new products and channels to boost Asian sales by 1.5x by 2027.
Plans to increase overseas sales ratio to 50% by 2027, leveraging local market strengths and cross-regional brand rollouts.
Latest events from Kao
- Record H1 profit and upgraded FY2026 outlook reflect strong growth in core and focus businesses.4452
Q2 2026 - DX investment, empowered talent, and data-driven strategies fuel global growth and innovation.4452
Status update - AI-powered marketing tools and global collaboration accelerate growth and profitability worldwide.4452
Status update - Strong sales and profit growth, aided by a land sale, with stable outlook despite global risks.4452
Q1 2026 - Profits and sales rose, with a share split and higher dividends planned for FY2026.4452
Q4 2025 - Profit and margin growth surged on reforms and premiumization, offsetting China cosmetics weakness.4452
Q3 2024 - H1 operating income up 68%, full-year outlook raised, but China remains a challenge.4452
Q2 2024 - Operating income jumped 41.9% on 6.6% sales growth, with robust gains in Japan.4452
Q1 2025 - Profit and ROIC surged on reforms; 2025 targets further growth and global expansion.4452
Q4 2024